Ad
related to: ngm stock
Search results
NGM Biopharmaceuticals (NGM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 years agoNGM Biopharmaceuticals (NGM) possesses the right combination of the two key ingredients for a likely...
Great week for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) institutional investors after losing 75%...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Given the large stake in the stock by institutions, NGM Biopharmaceuticals' stock price...
NGM Biopharmaceuticals (NGM) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 10 months agoNGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 0% and 42.30%,...
Institutional owners may consider drastic measures as NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM)...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Significantly high institutional ownership implies NGM Biopharmaceuticals' stock price...
NGM Biopharmaceuticals (NGM) Soars 6.8%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 2 years agoNGM Biopharmaceuticals (NGM) saw its shares surge in the last session with trading volume being...
Insiders Give Up US$292k As NGM Biopharmaceuticals Stock Drops To US$1.31
Simply Wall St. via Yahoo Finance· 9 months agoInsiders who acquired US$462k worth of NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) stock at an...
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) is definitely on the radar of institutional investors who...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM), it is...
Shareholders in NGM Biopharmaceuticals (NASDAQ:NGM) have lost 42%, as stock drops 6.5% this past...
Simply Wall St. via Yahoo Finance· 2 years agoInvestors can approximate the average market return by buying an index fund. While individual stocks...
How Much Upside is Left in NGM Biopharmaceuticals (NGM)? Wall Street Analysts Think 462%
Zacks via Yahoo Finance· 2 years agoThe mean of analysts' price targets for NGM Biopharmaceuticals (NGM) points to a 461.7% upside in...
NGM to go private through deal with investment firm
BioPharma Dive via Yahoo Finance· 3 months agoThe deal would mark a retreat from public markets for the once notable biotech, which was forced to cut staff last year to save cash after trial...
